CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Are M&As the Secret Mantra Propelling US Markets' Bull-Run?
by Ritujay Ghosh
Given the bullish economic outlook, robust corporate earnings and interest rates still remaining low in the United States, companies are going for mergers for future growth.
Pharmacies and Drug Stores Stock Outlook: Prospects Bright
by Zacks Equity Research
Amazon's entry into drug distribution is expected be a game changer but the immediate implications will be limited, given that the healthcare space is highly complex and regulated.
Walmart Soared, But Amazon (AMZN) Stock Is Still a Must Buy
by Benjamin Rains
Walmart (WMT) saw its stock price surge over 10% Thursday after the retail giant reported stronger-than-anticipated quarterly financial results. Yet, while some investors dive into WMT stock, the e-commerce powerhouse that forced Walmart to revamp its business model seems as strong as ever. So let's see why Amazon (AMZN) stock looks like a great buy right now.
CVS Health's PBM Selling Season Strong, Aetna Deal on Track
by Zacks Equity Research
A solid 2019 PBM selling season is a significant positive for CVS Health's (CVS) growth. The company completes more than 70% of its client renewals, almost in line with the prior-year level.
UnitedHealth to Spread in Pharmacy Business With Genoa Deal
by Zacks Equity Research
UnitedHealth's (UNH) acquisition of Genoa Health should aid the company's Optum segment.
Time to Buy Kroger (KR) Stock After Alibaba (BABA) Partnership?
by Benjamin Rains
Shares of Kroger (KR) surged over 2.3% Tuesday to inch close to their 52-week high after the company announced a partnership with Chinese e-commerce powerhouse and Amazon (AMZN) rival Alibaba (BABA). The deal marks the U.S. grocery giant's first push into international markets and represents the continuation of a much larger e-commerce venture.
Top Research Reports with Q2 Earnings Analysis: Merck, CVS Health, CME Group & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME).
CVS Health's (CVS) Q2 Earnings Beat Estimate, Margins Up
by Zacks Equity Research
CVS Health (CVS) reports strong Pharmacy Services revenues, benefiting from the upside in the specialty services. Year-over-year Retail/LTC comparisons are also encouraging.
Stock Index Futures Lower On Wednesday
by Zacks Equity Research
Stock Index Futures Lower On Wednesday
Indexes Start Lower As Trade Worries Persist
by Zacks Equity Research
U.S. stock index futures were lower on Wednesday as global trade war fears continue to dent investor confidence despite a robust second-quarter 2018 earnings season
Buy These 6 Low Price-to-Book Stocks for Handsome Returns
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
CVS Health (CVS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 4.97% and 0.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Buy Amazon (AMZN) Stock On Possible Gas Station & Travel Push?
by Benjamin Rains
Shares of Amazon (AMZN) popped Tuesday after D.A. Davidson analysts suggested that the next logical industries for the e-commerce giant to enter would be gas stations and travel. Amazon could likely jump into the gas station market without much fuss, similar to Costco (COST), and certainly has the online infrastructure and customer base to offer travel deals. But what should investors make of this?
Should Value Investors Pick CVS Health (CVS) Stock Now?
by Zacks Equity Research
Let's see if CVS Health Corporation (CVS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote
by Zacks Equity Research
Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.
Why Amazon (AMZN) Stock Is A Strong Buy Right Now
by Benjamin Rains
Nearly everyone knows that Amazon (AMZN) stock has been one of the hottest on Wall Street for years. Yet some assume now is too late to get in on the fun, which simply isn't true. So let's take a look at why investors should buy Amazon stock right now following yet another quarter of stellar growth.
Why Apple Pay, AirPods, & Services Are More Vital Than Ever
by Benjamin Rains
Apple (AAPL) saw its stock price climb Wednesday as it inches ever closer to that elusive $1 trillion market cap. The firm's iPhone revenues surged once again during its fiscal Q3, but investors seem much more excited about Apple's growing Services unit, which features Apple Music, Apple Pay, along with other newer businesses.
Apple Earnings Preview, Chipotle Woes, News from NAKD, CVS, SHOP | Free Lunch
by Ryan McQueeney
Ryan McQueeney discusses Chipotle's latest foodborne illness trouble, the new partnership between Naked Brands and CVS, and Shopify's earnings report. Later, he is joined by Zacks Strategist Brian Bolan to preview the upcoming earnings announcement of tech behemoth Apple.
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in the Cards for CVS Health (CVS) in Q2 Earnings?
by Zacks Equity Research
CVS Health (CVS) is optimistic about living up to its strong earnings surprise history year over year in Q2 as well, courtesy of gains from the Pharmacy Services segment.
5 Low Price-to-Book Stocks That Can Prove to be Valuable
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
One of Wall Street's Top Analysts Warns Against Trade War
by Chloe Shin
With the trade war looming upon us, Goldman Sachs chief U.S. equity strategist David Kostin warned investors about how it will affect U.S. Companies. According to Kostin, if trade tensions worsen, and a 10 percent tariff were imposed on all U.S. imports, Goldman would lower its 2019 S&P 500 EPS estimate by 15 percent.
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
by Zacks Equity Research
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols
5 Stocks Trading Near 52-Week High With More Room to Run
by Zacks Equity Research
Here are some stocks trading near their 52-week high levels with potential to scale higher.